GleamWall
中文EN

LUCY Innovative Eyewear Inc

Ophthalmic Goods · Nasdaq · SEC CIK 1808377 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY56.9%
TTM net income YoY-3.7%
TTM EPS YoY42.4%
Revenue 3-yr CAGR83.9%
Net income 3-yr CAGR—

Margins

Gross margin22.7%
Operating margin—
Net margin-216.8%
FCF margin—
EBITDA margin—

Returns

ROE-92.4%
ROA-84.0%
ROIC (approx.)—
Asset turnover0.39x

Leverage & solvency

Liabilities / assets10.2%
Debt / equity0.00x
Current ratio9.12x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.89x
Accruals ratio-9.1%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$1.01M$1.01M$773,561$959,810$668,128$579,230$454,501$690,688
Cost of revenue$688,786$768,004$598,116$845,064$423,291$591,895$233,968$596,969
Gross profit$320,910$242,515$175,445$114,746$244,837-$12,665$220,533$93,719
R&D expense$423,353$142,093$138,109$116,604$129,984$268,224$210,576$214,915
SG&A expense$1.58M$1.22M$1.59M$1.55M$1.28M$1.31M$1.09M$947,075
Income tax$0$0$0—$0$0$0—
Net income-$2.29M-$1.67M-$2.31M-$1.87M-$1.84M-$2.11M-$1.78M-$2.13M
EPS (basic)-0.27-0.26-0.37—-0.38-0.66-0.72—
EPS (diluted)-0.27-0.26-0.37—-0.38-0.66-0.72—
Weighted avg. shares (diluted)8.42M6.41M6.25M—4.87M3.21M2.45M—
Balance sheet
Cash & equivalents$3.20M$2.46M$4.38M$6.51M$6.70M$7.63M$5.26M$2.63M
Receivables$242,275$136,402$71,506$142,152$83,358$57,957$89,664$107,918
Inventory$1.68M$1.77M$1.40M$1.75M$1.63M$1.68M$1.13M$831,757
Current assets$7.56M$6.79M$8.75M$9.44M$10.60M$11.33M$7.33M$9.24M
PP&E, net$26,585$31,368$50,224$61,777$58,243$58,330$127,008$107,562
Intangibles$593,998$627,930$599,609$559,968$421,491$435,043$457,750$451,302
Total assets$8.21M$7.47M$9.48M$10.14M$11.18M$11.94M$7.94M$9.84M
Current liabilities$829,291$562,726$1.09M$1.05M$884,651$606,060$447,241$737,718
Total liabilities$836,314$574,385$1.11M$1.07M$925,003$658,518$447,241$743,168
Shareholders' equity$7.37M$6.90M$8.37M$9.07M$10.25M$11.28M$7.49M$9.10M
Shares outstanding8.71M6.41M6.30M5.48M5.21M4.57M2.45M2.45M
Cash flow statement
Operating cash flow-$1.55M-$1.86M-$2.49M-$1.35M-$1.50M-$2.12M-$2.31M-$1.94M
Capital expenditure———$17,030$14,835$0$40,648$26,455
Free cash flow———-$1.37M-$1.51M-$2.12M-$2.35M-$1.97M
Investing cash flow-$283,370-$26,510-$1.05M$824,870-$14,835-$1.27M$4.94M-$61,421
Financing cash flow$2.57M-$32,433$1.40M$336,965$584,402——$89,851
Depreciation & amortization$4,783$8,431$11,553$13,496$14,922$17,168$21,202$25,582
Stock-based compensation$198,325$198,325$200,992$206,153$169,304$164,714$177,576$264,254

Free plan shows the latest 8 periods; Pro shows all 23 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.